Pancreasrák. A Magyar Hasnyálmirigy Munkacsoport bizonyítékon alapuló kezelési irányelvei

Translated title of the contribution: Pancreatic cancer: Evidence based management guidelines of the Hungarian Pancreatic Study Group

R. Szmola, Gyula Farkas, P. Hegyi, L. Czakó, Zsolt Dubravcsik, I. Hritz, Dezso Kelemen, Natália Lásztity, Zita Morvay, A. Oláh, Andrea Párniczky, Gábor Rubovszky, Miklós Sahin-Tóth, Zsolt Szentkereszti, Ákos Szücs, T. Takács, L. Tiszlavicz, A. Pap, Magyar Hasnyálmirigy Munkacsoport

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Pancreatic cancer is a disease with a poor prognosis usually diagnosed at a late stage. Therefore, screening, diagnosis, treatment and palliation of pancreatic cancer patients require up-to-date and evidence based management guidelines. The Hungarian Pancreatic Study Group proposed to prepare an evidence based guideline based on the available scientific evidence and international guidelines. The preparatory and consultation board appointed by the Hungarian Pancreatic Study Group translated and complemented/modified the recent international guidelines. 37 clinical statements in 10 major topics were defined (Risk factors and genetics, Screening, Diagnosis, Staging, Surgical care, Pathology, Systemic treatment, Radiation therapy, Palliation and supportive care, Follow-up and recurrence). Evidence was graded according to the National Comprehensive Cancer Network (NCCN) grading system. The draft of the guideline was presented and discussed at the consensus meeting in September 12, 2014. Statements were accepted with either total (more than 95% of votes, n = 15) or strong agreement (more than 70% of votes, n = 22). The present guideline is the first evidence based pancreatic cancer guideline in Hungary that provides a solid ground for teaching purposes, offers quick reference in everyday patient care and guides patient financing options. The authors strongly believe that these guidelines will become a standard reference for pancreatic cancer treatment in Hungary.

Original languageHungarian
Pages (from-to)326-339
Number of pages14
JournalOrvosi Hetilap
Volume156
Issue number8
DOIs
Publication statusPublished - Feb 1 2015

Fingerprint

Pancreatic Neoplasms
Guidelines
Hungary
Surgical Pathology
Aftercare
Genetic Testing
Patient Care
Teaching
Radiotherapy
Therapeutics
Referral and Consultation
Recurrence
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pancreasrák. A Magyar Hasnyálmirigy Munkacsoport bizonyítékon alapuló kezelési irányelvei. / Szmola, R.; Farkas, Gyula; Hegyi, P.; Czakó, L.; Dubravcsik, Zsolt; Hritz, I.; Kelemen, Dezso; Lásztity, Natália; Morvay, Zita; Oláh, A.; Párniczky, Andrea; Rubovszky, Gábor; Sahin-Tóth, Miklós; Szentkereszti, Zsolt; Szücs, Ákos; Takács, T.; Tiszlavicz, L.; Pap, A.; Munkacsoport, Magyar Hasnyálmirigy.

In: Orvosi Hetilap, Vol. 156, No. 8, 01.02.2015, p. 326-339.

Research output: Contribution to journalArticle

Szmola, R, Farkas, G, Hegyi, P, Czakó, L, Dubravcsik, Z, Hritz, I, Kelemen, D, Lásztity, N, Morvay, Z, Oláh, A, Párniczky, A, Rubovszky, G, Sahin-Tóth, M, Szentkereszti, Z, Szücs, Á, Takács, T, Tiszlavicz, L, Pap, A & Munkacsoport, MH 2015, 'Pancreasrák. A Magyar Hasnyálmirigy Munkacsoport bizonyítékon alapuló kezelési irányelvei', Orvosi Hetilap, vol. 156, no. 8, pp. 326-339. https://doi.org/10.1556/OH.2015.30063
Szmola, R. ; Farkas, Gyula ; Hegyi, P. ; Czakó, L. ; Dubravcsik, Zsolt ; Hritz, I. ; Kelemen, Dezso ; Lásztity, Natália ; Morvay, Zita ; Oláh, A. ; Párniczky, Andrea ; Rubovszky, Gábor ; Sahin-Tóth, Miklós ; Szentkereszti, Zsolt ; Szücs, Ákos ; Takács, T. ; Tiszlavicz, L. ; Pap, A. ; Munkacsoport, Magyar Hasnyálmirigy. / Pancreasrák. A Magyar Hasnyálmirigy Munkacsoport bizonyítékon alapuló kezelési irányelvei. In: Orvosi Hetilap. 2015 ; Vol. 156, No. 8. pp. 326-339.
@article{22ea450ce3f544fdbbc860f43dfb3cf5,
title = "Pancreasr{\'a}k. A Magyar Hasny{\'a}lmirigy Munkacsoport bizony{\'i}t{\'e}kon alapul{\'o} kezel{\'e}si ir{\'a}nyelvei",
abstract = "Pancreatic cancer is a disease with a poor prognosis usually diagnosed at a late stage. Therefore, screening, diagnosis, treatment and palliation of pancreatic cancer patients require up-to-date and evidence based management guidelines. The Hungarian Pancreatic Study Group proposed to prepare an evidence based guideline based on the available scientific evidence and international guidelines. The preparatory and consultation board appointed by the Hungarian Pancreatic Study Group translated and complemented/modified the recent international guidelines. 37 clinical statements in 10 major topics were defined (Risk factors and genetics, Screening, Diagnosis, Staging, Surgical care, Pathology, Systemic treatment, Radiation therapy, Palliation and supportive care, Follow-up and recurrence). Evidence was graded according to the National Comprehensive Cancer Network (NCCN) grading system. The draft of the guideline was presented and discussed at the consensus meeting in September 12, 2014. Statements were accepted with either total (more than 95{\%} of votes, n = 15) or strong agreement (more than 70{\%} of votes, n = 22). The present guideline is the first evidence based pancreatic cancer guideline in Hungary that provides a solid ground for teaching purposes, offers quick reference in everyday patient care and guides patient financing options. The authors strongly believe that these guidelines will become a standard reference for pancreatic cancer treatment in Hungary.",
keywords = "Evidence based medicine, guideline, pancreatic cancer",
author = "R. Szmola and Gyula Farkas and P. Hegyi and L. Czak{\'o} and Zsolt Dubravcsik and I. Hritz and Dezso Kelemen and Nat{\'a}lia L{\'a}sztity and Zita Morvay and A. Ol{\'a}h and Andrea P{\'a}rniczky and G{\'a}bor Rubovszky and Mikl{\'o}s Sahin-T{\'o}th and Zsolt Szentkereszti and {\'A}kos Sz{\"u}cs and T. Tak{\'a}cs and L. Tiszlavicz and A. Pap and Munkacsoport, {Magyar Hasny{\'a}lmirigy}",
year = "2015",
month = "2",
day = "1",
doi = "10.1556/OH.2015.30063",
language = "Hungarian",
volume = "156",
pages = "326--339",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "8",

}

TY - JOUR

T1 - Pancreasrák. A Magyar Hasnyálmirigy Munkacsoport bizonyítékon alapuló kezelési irányelvei

AU - Szmola, R.

AU - Farkas, Gyula

AU - Hegyi, P.

AU - Czakó, L.

AU - Dubravcsik, Zsolt

AU - Hritz, I.

AU - Kelemen, Dezso

AU - Lásztity, Natália

AU - Morvay, Zita

AU - Oláh, A.

AU - Párniczky, Andrea

AU - Rubovszky, Gábor

AU - Sahin-Tóth, Miklós

AU - Szentkereszti, Zsolt

AU - Szücs, Ákos

AU - Takács, T.

AU - Tiszlavicz, L.

AU - Pap, A.

AU - Munkacsoport, Magyar Hasnyálmirigy

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Pancreatic cancer is a disease with a poor prognosis usually diagnosed at a late stage. Therefore, screening, diagnosis, treatment and palliation of pancreatic cancer patients require up-to-date and evidence based management guidelines. The Hungarian Pancreatic Study Group proposed to prepare an evidence based guideline based on the available scientific evidence and international guidelines. The preparatory and consultation board appointed by the Hungarian Pancreatic Study Group translated and complemented/modified the recent international guidelines. 37 clinical statements in 10 major topics were defined (Risk factors and genetics, Screening, Diagnosis, Staging, Surgical care, Pathology, Systemic treatment, Radiation therapy, Palliation and supportive care, Follow-up and recurrence). Evidence was graded according to the National Comprehensive Cancer Network (NCCN) grading system. The draft of the guideline was presented and discussed at the consensus meeting in September 12, 2014. Statements were accepted with either total (more than 95% of votes, n = 15) or strong agreement (more than 70% of votes, n = 22). The present guideline is the first evidence based pancreatic cancer guideline in Hungary that provides a solid ground for teaching purposes, offers quick reference in everyday patient care and guides patient financing options. The authors strongly believe that these guidelines will become a standard reference for pancreatic cancer treatment in Hungary.

AB - Pancreatic cancer is a disease with a poor prognosis usually diagnosed at a late stage. Therefore, screening, diagnosis, treatment and palliation of pancreatic cancer patients require up-to-date and evidence based management guidelines. The Hungarian Pancreatic Study Group proposed to prepare an evidence based guideline based on the available scientific evidence and international guidelines. The preparatory and consultation board appointed by the Hungarian Pancreatic Study Group translated and complemented/modified the recent international guidelines. 37 clinical statements in 10 major topics were defined (Risk factors and genetics, Screening, Diagnosis, Staging, Surgical care, Pathology, Systemic treatment, Radiation therapy, Palliation and supportive care, Follow-up and recurrence). Evidence was graded according to the National Comprehensive Cancer Network (NCCN) grading system. The draft of the guideline was presented and discussed at the consensus meeting in September 12, 2014. Statements were accepted with either total (more than 95% of votes, n = 15) or strong agreement (more than 70% of votes, n = 22). The present guideline is the first evidence based pancreatic cancer guideline in Hungary that provides a solid ground for teaching purposes, offers quick reference in everyday patient care and guides patient financing options. The authors strongly believe that these guidelines will become a standard reference for pancreatic cancer treatment in Hungary.

KW - Evidence based medicine

KW - guideline

KW - pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84922637691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922637691&partnerID=8YFLogxK

U2 - 10.1556/OH.2015.30063

DO - 10.1556/OH.2015.30063

M3 - Article

VL - 156

SP - 326

EP - 339

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 8

ER -